Pain Blocking During Drug Administration or Blood Collection With Needles

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Montana Compton, University of California, Irvine
ClinicalTrials.gov Identifier:
NCT01166906
First received: July 20, 2010
Last updated: December 9, 2013
Last verified: December 2013
  Purpose

There is a gating mechanism in the dorsal horn of the spinal cord that acts to facilitate or inhibit transmission of pain signals to the brain. The gate can be closed by mechanical stimuli such as touch and vibration.


Condition Intervention
Pain, Intractable
Device: pain blocking

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Pain Blocking During Drug Administration or Blood Collection With Needles

Further study details as provided by University of California, Irvine:

Primary Outcome Measures:
  • Pain Blocking During Drug Administration or Blood Collection With Needles [ Time Frame: up to 12 months ] [ Designated as safety issue: No ]
    Pain Blocking During Drug Administration or Blood Collection With Needles


Estimated Enrollment: 100
Study Start Date: March 2010
Estimated Study Completion Date: March 2015
Estimated Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)
Intervention Details:
    Device: pain blocking
    pain blocking
Detailed Description:

The researcher develope a device that can use to reduce pain during drug administration or blood collection with needles.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

primary care clinic, community sample,

Criteria

Inclusion Criteria:

  • Receiving an injection with a needle
  • Able to score the pain on a scale of 0-10 using the universal pain assessment tool, preferably 7 years of age or older

Exclusion Criteria:

  • Current pregnancy
  • Inability to understand and carry out instruction
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01166906

Locations
United States, California
Beckman Laser Institute Medical clinic
Irvine, California, United States, 92612
Sponsors and Collaborators
Montana Compton
Investigators
Principal Investigator: Wangcun Jia, PhD Beckman Laser Institute University of California Irvine
  More Information

No publications provided

Responsible Party: Montana Compton, Administrative Nurse Research Coordinator Beckman Laser Institute, University of California, Irvine
ClinicalTrials.gov Identifier: NCT01166906     History of Changes
Other Study ID Numbers: NIH NIBIB;HS#2009-7245
Study First Received: July 20, 2010
Last Updated: December 9, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by University of California, Irvine:
pain blocking

Additional relevant MeSH terms:
Pain, Intractable
Pain
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms

ClinicalTrials.gov processed this record on April 17, 2014